Forte Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 08/14/2024 | 3.62 M | $1.95 M | 0.00% | 7.87% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 3.27 M | $1.75 M | 0.00% | 7.09% |
| BVF INC/IL | 08/14/2024 | 2.98 M | $1.60 M | 0.00% | 6.47% |
| CABLE CAR CAPITAL LLC | 08/14/2024 | 2.03 M | $1.09 M | 0.00% | 4.41% |
| FRED ALGER MANAGEMENT, LLC | 08/14/2024 | 1.84 M | $987,524 | 0.00% | 3.99% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.81 M | $972,214 | 0.00% | 3.93% |
| BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 1.76 M | $946,034 | 0.00% | 3.82% |
| VANGUARD GROUP INC | 08/13/2024 | 665,230 | $357,228 | 0.00% | 1.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 346,292 | $186,008 | 0.83% | 0.75% |
| BLACKROCK INC. | 08/13/2024 | 174,858 | $93,899 | 0.00% | 0.38% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 159,258 | $85,522 | -6.60% | 0.35% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 133,400 | $71,636 | 0.98% | 0.29% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 40,811 | $21,916 | -0.13% | 0.09% |
| STATE STREET CORP | 08/14/2024 | 37,564 | $20,172 | -9.84% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 34,344 | $18,443 | 100.00% | 0.07% |
| NORTHERN TRUST CORP | 08/14/2024 | 26,817 | $14,401 | -0.35% | 0.06% |
| UBS GROUP AG | 08/14/2024 | 24,310 | $13,055 | 73,566.67% | 0.05% |
| 09/05/2024 | 22,014 | $15,769 | 100.00% | 0.05% | |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 20,776 | $11,157 | 0.01% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 15,798 | $8,484 | 35.70% | 0.03% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 14,017 | $7,527 | -3.51% | 0.03% |
| ARIES WEALTH MANAGEMENT | 07/25/2024 | 13,000 | $6,981 | 0.00% | 0.03% |
| HSBC HOLDINGS PLC | 08/12/2024 | 10,745 | $5,888 | 0.00% | 0.02% |
| CITADEL ADVISORS LLC | 08/14/2024 | 8,097 | $4,348 | -71.31% | 0.02% |
| MORGAN STANLEY | 10/17/2024 | 3,804 | $2,043 | 282.70% | 0.01% |
| CITADEL ADVISORS LLC | 08/14/2024 | 3,100 | $1,665 | 210.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 1,080 | $582 | 0.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 453 | $243 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 265 | $142 | 100.00% | 0.00% |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 07/17/2024 | 193 | $112 | 0.00% | 0.00% |
| FMR LLC | 08/13/2024 | 128 | $69 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 17 | $9 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 3 | $2 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Forte Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Forte Biosciences, Inc.. The most heavily invested institutionals were:
Tower Research Capital LLC (TRC): 0
Cable Car Capital LLC: 0
GROUP ONE TRADING, L.P.: 0
NORTHERN TRUST CORP: 0
BANK OF AMERICA CORP /DE/: 0
FMR LLC: 0
41.38% of Forte Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 245,256 shares in the last 24 months. This purchase volume represents approximately $3.56 M in transactions.